To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision

Bibliographic Details
Main Author: Nobre, Yuri D. [UNIFESP]
Publication Date: 2010
Other Authors: Freitas, Ricardo G. [UNIFESP], Felizardo, Maria J. [UNIFESP], Ortiz, Valdemar [UNIFESP], Macedo Junior, Antonio [UNIFESP]
Format: Article
Language: eng
Source: Repositório Institucional da UNIFESP
Download full: http://repositorio.unifesp.br/handle/11600/5606
http://dx.doi.org/10.1590/S1677-55382010000100012
Summary: PURPOSE: To compare the efficacy and costs of circumcision versus topical treatment using a prospective pharmacoeconomic protocol. MATERIALS AND METHODS: We treated 59 patients (3-10 years of age) randomized into two groups: 29 underwent an 8-week course of topical treatment with 0.2% betamethasone-hyaluronidase cream twice a day; and 30 underwent circumcision. Topical treatment success was defined as complete exposure of the glans. In cases of treatment failure, circumcision was performed and its cost imputed to that of the initial treatment. The pharmacoeconomic aspects were defined according to the Brazilian National Public Health System database and the Brazilian Community Pharmacies Index. RESULTS: The two groups were statistically similar for all clinical parameters evaluated. Topical treatment resulted in complete exposure of the glans in 52% of the patients. Topical treatment was associated with preputial pain and hyperemia. However, treatment suspension was unnecessary. Minor complications were observed in 16.6% of the surgical group patients. The mean cost per patient was US$ 53.70 and US$ 125.20, respectively, for topical steroid treatment (including the costs related to treatment failure) and circumcision. The total costs were US$ 2,825.32 and US$ 3,885.73 for topical treatment and circumcision, respectively. CONCLUSIONS: Topical treatment of phimosis can reduce costs by 27.3% in comparison with circumcision. Therefore, topical treatment of phimosis should be considered prior to the decision to perform surgery.
id UFSP_fe2551c1e1a44f30965b9205c2003882
oai_identifier_str oai:repositorio.unifesp.br:11600/5606
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Nobre, Yuri D. [UNIFESP]Freitas, Ricardo G. [UNIFESP]Felizardo, Maria J. [UNIFESP]Ortiz, Valdemar [UNIFESP]Macedo Junior, Antonio [UNIFESP]Universidade Federal de São Paulo (UNIFESP)2015-06-14T13:41:32Z2015-06-14T13:41:32Z2010-02-01International braz j urol. Sociedade Brasileira de Urologia, v. 36, n. 1, p. 75-85, 2010.1677-5538http://repositorio.unifesp.br/handle/11600/5606http://dx.doi.org/10.1590/S1677-55382010000100012S1677-55382010000100012.pdfS1677-5538201000010001210.1590/S1677-55382010000100012WOS:000283288200025PURPOSE: To compare the efficacy and costs of circumcision versus topical treatment using a prospective pharmacoeconomic protocol. MATERIALS AND METHODS: We treated 59 patients (3-10 years of age) randomized into two groups: 29 underwent an 8-week course of topical treatment with 0.2% betamethasone-hyaluronidase cream twice a day; and 30 underwent circumcision. Topical treatment success was defined as complete exposure of the glans. In cases of treatment failure, circumcision was performed and its cost imputed to that of the initial treatment. The pharmacoeconomic aspects were defined according to the Brazilian National Public Health System database and the Brazilian Community Pharmacies Index. RESULTS: The two groups were statistically similar for all clinical parameters evaluated. Topical treatment resulted in complete exposure of the glans in 52% of the patients. Topical treatment was associated with preputial pain and hyperemia. However, treatment suspension was unnecessary. Minor complications were observed in 16.6% of the surgical group patients. The mean cost per patient was US$ 53.70 and US$ 125.20, respectively, for topical steroid treatment (including the costs related to treatment failure) and circumcision. The total costs were US$ 2,825.32 and US$ 3,885.73 for topical treatment and circumcision, respectively. CONCLUSIONS: Topical treatment of phimosis can reduce costs by 27.3% in comparison with circumcision. Therefore, topical treatment of phimosis should be considered prior to the decision to perform surgery.Federal University of São Paulo Department of Urology Section of Pediatric UrologyUNIFESP, Department of Urology Section of Pediatric UrologySciELO75-85engSociedade Brasileira de UrologiaInternational braz j urolphimosiscircumcisionmalesteroidspharmacoeconomicsTo circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcisioninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALS1677-55382010000100012.pdfapplication/pdf824986${dspace.ui.url}/bitstream/11600/5606/1/S1677-55382010000100012.pdf43111243993058aac481459efce05b50MD51open accessTEXTS1677-55382010000100012.pdf.txtS1677-55382010000100012.pdf.txtExtracted texttext/plain28724${dspace.ui.url}/bitstream/11600/5606/21/S1677-55382010000100012.pdf.txta877416ab86c2b48afb50966af79df9aMD521open accessTHUMBNAILS1677-55382010000100012.pdf.jpgS1677-55382010000100012.pdf.jpgIM Thumbnailimage/jpeg6567${dspace.ui.url}/bitstream/11600/5606/23/S1677-55382010000100012.pdf.jpg0f67e704d3f41874cb3e99b5df013f86MD523open access11600/56062023-06-05 20:05:04.873open accessoai:repositorio.unifesp.br:11600/5606Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-06-05T23:05:04Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision
title To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision
spellingShingle To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision
Nobre, Yuri D. [UNIFESP]
phimosis
circumcision
male
steroids
pharmacoeconomics
title_short To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision
title_full To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision
title_fullStr To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision
title_full_unstemmed To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision
title_sort To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision
author Nobre, Yuri D. [UNIFESP]
author_facet Nobre, Yuri D. [UNIFESP]
Freitas, Ricardo G. [UNIFESP]
Felizardo, Maria J. [UNIFESP]
Ortiz, Valdemar [UNIFESP]
Macedo Junior, Antonio [UNIFESP]
author_role author
author2 Freitas, Ricardo G. [UNIFESP]
Felizardo, Maria J. [UNIFESP]
Ortiz, Valdemar [UNIFESP]
Macedo Junior, Antonio [UNIFESP]
author2_role author
author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Nobre, Yuri D. [UNIFESP]
Freitas, Ricardo G. [UNIFESP]
Felizardo, Maria J. [UNIFESP]
Ortiz, Valdemar [UNIFESP]
Macedo Junior, Antonio [UNIFESP]
dc.subject.eng.fl_str_mv phimosis
circumcision
male
steroids
pharmacoeconomics
topic phimosis
circumcision
male
steroids
pharmacoeconomics
description PURPOSE: To compare the efficacy and costs of circumcision versus topical treatment using a prospective pharmacoeconomic protocol. MATERIALS AND METHODS: We treated 59 patients (3-10 years of age) randomized into two groups: 29 underwent an 8-week course of topical treatment with 0.2% betamethasone-hyaluronidase cream twice a day; and 30 underwent circumcision. Topical treatment success was defined as complete exposure of the glans. In cases of treatment failure, circumcision was performed and its cost imputed to that of the initial treatment. The pharmacoeconomic aspects were defined according to the Brazilian National Public Health System database and the Brazilian Community Pharmacies Index. RESULTS: The two groups were statistically similar for all clinical parameters evaluated. Topical treatment resulted in complete exposure of the glans in 52% of the patients. Topical treatment was associated with preputial pain and hyperemia. However, treatment suspension was unnecessary. Minor complications were observed in 16.6% of the surgical group patients. The mean cost per patient was US$ 53.70 and US$ 125.20, respectively, for topical steroid treatment (including the costs related to treatment failure) and circumcision. The total costs were US$ 2,825.32 and US$ 3,885.73 for topical treatment and circumcision, respectively. CONCLUSIONS: Topical treatment of phimosis can reduce costs by 27.3% in comparison with circumcision. Therefore, topical treatment of phimosis should be considered prior to the decision to perform surgery.
publishDate 2010
dc.date.issued.fl_str_mv 2010-02-01
dc.date.accessioned.fl_str_mv 2015-06-14T13:41:32Z
dc.date.available.fl_str_mv 2015-06-14T13:41:32Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv International braz j urol. Sociedade Brasileira de Urologia, v. 36, n. 1, p. 75-85, 2010.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/5606
http://dx.doi.org/10.1590/S1677-55382010000100012
dc.identifier.issn.none.fl_str_mv 1677-5538
dc.identifier.file.none.fl_str_mv S1677-55382010000100012.pdf
dc.identifier.scielo.none.fl_str_mv S1677-55382010000100012
dc.identifier.doi.none.fl_str_mv 10.1590/S1677-55382010000100012
dc.identifier.wos.none.fl_str_mv WOS:000283288200025
identifier_str_mv International braz j urol. Sociedade Brasileira de Urologia, v. 36, n. 1, p. 75-85, 2010.
1677-5538
S1677-55382010000100012.pdf
S1677-55382010000100012
10.1590/S1677-55382010000100012
WOS:000283288200025
url http://repositorio.unifesp.br/handle/11600/5606
http://dx.doi.org/10.1590/S1677-55382010000100012
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv International braz j urol
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 75-85
dc.publisher.none.fl_str_mv Sociedade Brasileira de Urologia
publisher.none.fl_str_mv Sociedade Brasileira de Urologia
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/5606/1/S1677-55382010000100012.pdf
${dspace.ui.url}/bitstream/11600/5606/21/S1677-55382010000100012.pdf.txt
${dspace.ui.url}/bitstream/11600/5606/23/S1677-55382010000100012.pdf.jpg
bitstream.checksum.fl_str_mv 43111243993058aac481459efce05b50
a877416ab86c2b48afb50966af79df9a
0f67e704d3f41874cb3e99b5df013f86
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1783460322176139264